Literature DB >> 25515210

Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease.

Jack A Wells1, Holly E Holmes1, James M O'Callaghan1, Niall Colgan1, Ozama Ismail1, Elizabeth Mc Fisher2, Bernard Siow1, Tracey K Murray3, Adam J Schwarz4, Michael J O'Neill3, Emily C Collins4, Mark F Lythgoe1.   

Abstract

Vascular abnormalities are a key feature of Alzheimer's disease (AD). Imaging of cerebral vascular reactivity (CVR) is a powerful tool to investigate vascular health in clinical populations although the cause of reduced CVR in AD patients is not fully understood. We investigated the specific role of tau pathology in CVR derangement in AD using the rTg4510 mouse model. We observed an increase in CVR in cortical regions with tau pathology. These data suggest that tau pathology alone does not produce the clinically observed decreases in CVR and implicates amyloid pathology as the dominant etiology of impaired CVR in AD patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25515210      PMCID: PMC4348392          DOI: 10.1038/jcbfm.2014.224

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  27 in total

Review 1.  Neurovascular mechanisms of Alzheimer's neurodegeneration.

Authors:  Berislav V Zlokovic
Journal:  Trends Neurosci       Date:  2005-04       Impact factor: 13.837

2.  Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy.

Authors:  Karl-Jürgen Bär; Michael Karl Boettger; Nicole Seidler; Hans Joachim Mentzel; Christoph Terborg; Heinrich Sauer
Journal:  Stroke       Date:  2007-10-25       Impact factor: 7.914

3.  Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain.

Authors:  Tetsuaki Arai; Judith Miklossy; Andis Klegeris; Jian-Ping Guo; Patrick L McGeer
Journal:  J Neuropathol Exp Neurol       Date:  2006-01       Impact factor: 3.685

4.  Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).

Authors:  Martin Ramsden; Linda Kotilinek; Colleen Forster; Jennifer Paulson; Eileen McGowan; Karen SantaCruz; Aaron Guimaraes; Mei Yue; Jada Lewis; George Carlson; Michael Hutton; Karen H Ashe
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

5.  Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study.

Authors:  Naruhiko Sahara; Pablo D Perez; Wen-Lang Lin; Dennis W Dickson; Yan Ren; Huadong Zeng; Jada Lewis; Marcelo Febo
Journal:  Neurobiol Aging       Date:  2013-12-19       Impact factor: 4.673

6.  Tau suppression in a neurodegenerative mouse model improves memory function.

Authors:  K Santacruz; J Lewis; T Spires; J Paulson; L Kotilinek; M Ingelsson; A Guimaraes; M DeTure; M Ramsden; E McGowan; C Forster; M Yue; J Orne; C Janus; A Mariash; M Kuskowski; B Hyman; M Hutton; K H Ashe
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

Review 7.  Alzheimer disease as a vascular disorder: nosological evidence.

Authors:  J C de la Torre
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

8.  Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial Doppler study.

Authors:  Edoardo Vicenzini; Maria Chiara Ricciardi; Marta Altieri; Francesco Puccinelli; Novella Bonaffini; Vittorio Di Piero; Gian Luigi Lenzi
Journal:  Eur Neurol       Date:  2007-06-12       Impact factor: 1.710

9.  Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.

Authors:  Hwa Kyoung Shin; Phillip B Jones; Monica Garcia-Alloza; Laura Borrelli; Steven M Greenberg; Brian J Bacskai; Matthew P Frosch; Bradley T Hyman; Michael A Moskowitz; Cenk Ayata
Journal:  Brain       Date:  2007-07-16       Impact factor: 13.501

10.  Cerebral blood flow MRI in mice using the cardiac-spin-labeling technique.

Authors:  Eric R Muir; Qiang Shen; Timothy Q Duong
Journal:  Magn Reson Med       Date:  2008-09       Impact factor: 4.668

View more
  17 in total

1.  Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510).

Authors:  Jieun Kim; In-Young Choi; Karen E Duff; Phil Lee
Journal:  Neurochem Res       Date:  2017-05-18       Impact factor: 3.996

Review 2.  The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

3.  Quantitative cerebrovascular reactivity MRI in mice using acetazolamide challenge.

Authors:  Zhiliang Wei; Yuguo Li; Xirui Hou; Zheng Han; Jiadi Xu; Michael T McMahon; Wenzhen Duan; Guanshu Liu; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2022-06-17       Impact factor: 3.737

4.  Brain metabolism in tau and amyloid mouse models of Alzheimer's disease: An MRI study.

Authors:  Zhiliang Wei; Jiadi Xu; Lin Chen; Lydiane Hirschler; Emmanuel L Barbier; Tong Li; Philip C Wong; Hanzhang Lu
Journal:  NMR Biomed       Date:  2021-05-29       Impact factor: 4.478

5.  Imaging the accumulation and suppression of tau pathology using multiparametric MRI.

Authors:  Holly E Holmes; Niall Colgan; Ozama Ismail; Da Ma; Nick M Powell; James M O'Callaghan; Ian F Harrison; Ross A Johnson; Tracey K Murray; Zeshan Ahmed; Morton Heggenes; Alice Fisher; M J Cardoso; Marc Modat; Simon Walker-Samuel; Elizabeth M C Fisher; Sebastien Ourselin; Michael J O'Neill; Jack A Wells; Emily C Collins; Mark F Lythgoe
Journal:  Neurobiol Aging       Date:  2015-12-15       Impact factor: 4.673

6.  Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.

Authors:  Thomas Blackmore; Soraya Meftah; Tracey Karen Murray; Peter James Craig; Anthony Blockeel; Keith Phillips; Brian Eastwood; Michael J O'Neill; Hugh Marston; Zeshan Ahmed; Gary Gilmour; Francois Gastambide
Journal:  Alzheimers Res Ther       Date:  2017-09-20       Impact factor: 6.982

7.  Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease.

Authors:  Illsung L Joo; Aaron Y Lai; Paolo Bazzigaluppi; Margaret M Koletar; Adrienne Dorr; Mary E Brown; Lynsie A M Thomason; John G Sled; JoAnne McLaurin; Bojana Stefanovic
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

8.  Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

Authors:  J J Chen
Journal:  Front Aging Neurosci       Date:  2018-06-05       Impact factor: 5.750

9.  Study the Longitudinal in vivo and Cross-Sectional ex vivo Brain Volume Difference for Disease Progression and Treatment Effect on Mouse Model of Tauopathy Using Automated MRI Structural Parcellation.

Authors:  Da Ma; Holly E Holmes; Manuel J Cardoso; Marc Modat; Ian F Harrison; Nick M Powell; James M O'Callaghan; Ozama Ismail; Ross A Johnson; Michael J O'Neill; Emily C Collins; Mirza F Beg; Karteek Popuri; Mark F Lythgoe; Sebastien Ourselin
Journal:  Front Neurosci       Date:  2019-01-24       Impact factor: 4.677

10.  Influence of different isoflurane anesthesia protocols on murine cerebral hemodynamics measured with pseudo-continuous arterial spin labeling.

Authors:  Leon P Munting; Marc P P Derieppe; Ernst Suidgeest; Baudouin Denis de Senneville; Jack A Wells; Louise van der Weerd
Journal:  NMR Biomed       Date:  2019-06-07       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.